Stella Diagnostics Inc.
SLDX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17 | $10 | $13 | $39 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $7 | $6 | $8 | $7 |
| Enterprise Value | $24 | $16 | $21 | $46 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$6 | -$5 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$6 | -$6 | -$17 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.003 | -0.019 | -0.034 | -0.17 |
| % Growth | 83.7% | 44.4% | 79.9% | – |
| Operating Cash Flow | -$0 | -$2 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$2 | -$0 | -$0 |